Propiontherapeutics
Propiontherapeutics

Nicholas Tubach

Chief Executive Officer

Nicholas Tubach is a serial biotech entrepreneur. In addition to his work as the CEO of Propion AKA How to Slow Time, Inc., he is the cofounder of three pharmaceutical companies developing treatments for chronic diseases and acute brain damage. Nicholas also studies Molecular & Cell Biology at UC Berkeley.

Propiontherapeutics
Propiontherapeutics

Dr. Jan Scicinski

Head of Medicinal Chemistry

Dr Jan Scicinski is an experienced drug discovery and development scientist, executive, and problem solver with a successful track record in new pharmaceutical product discovery and development.

He has more than 30 years experience in the pharmaceutical and biotech industries, in both start-up and large corporate environments (GSK, Nuada, ALZA, EpicentRx), providing leadership for programs in drug discovery from hit identification to lead selection and for development projects including CMC, IND-enabling activities, clinical trial operations and regulatory filings and communication.

Dr. Scicinski is a Fellow of the Royal Society of Chemistry with Chartered Chemist Status and holds a PhD from Cambridge University and BSc hons from Imperial College, London. He has co-authored over 170 peer-reviewed publications, patents, abstracts and book chapters.

Propiontherapeutics
Propiontherapeutics

Dr. Daniel Winer

Scientific Director

Dr. Daniel Winer is an Associate Professor at the Buck Institute for Research on Aging with affiliation to the University of Southern California. He is also an Assistant Professor at the University of Toronto, Departments of Laboratory Medicine and Pathobiology, and Immunology, and Affiliate Scientist at the Toronto General Research Institute.

Dr. Winer is known as an early adopter and promoter of three emerging fields in science, immunometabolism, mechanoimmunology, and astroimmunology. Within immunometabolism, Dr. Winer studies how gut microbiota intersects with the gut immune system to control metabolic and age related disease. He is the recipient of multiple awards in this field, including an Amgen Early Investigator Award and a Canada Research Chair.

Propiontherapeutics
Propiontherapeutics

Marco Quarta

Strategic Advisor

Dr. Marco Quarta earned a Masters degree in Biotechnology, a PhD in Neuroscience, and post-doctoral training in Aging and Stem Cells Biology at Stanford University School of Medicine. He then directed at Stanford School of Medicine/VA Hospital Palo Alto a research team focused on translational medical research in the fields of aging and regenerative medicine.

He is now founder and CEO of Rubedo Life Sciences, driving its mission to develop treatments for chronic age-related diseases and extend healthspan, and co-founder of the rejuvenation company, Turn Biotechnologies, based on his work conducted at Stanford University on transient epigenetic reprogramming. He additionally sits on the advisory board of the California Institute for Regenerative Medicine (CIRM) and research board at the Center for Healthcare Innovation (CHI).

Propiontherapeutics
Propiontherapeutics

Dr. Amine Zorgani

Operational Board Member

Amine, is a microbiome expert on a mission to save the human microbiome from extinction. Leveraging over a decade of research experience, he is at the forefront of efforts to unlock the potential of the microbiome.

An engaging speaker at high-profile industry conferences, he shares his passion for realizing the microbiome’s potential to transform medicine. Amine’s microbiome posts grab the attention of over 2.6 millions in the past year alone. He leads his team with an infectious optimism that, together, they can push scientific boundaries. His mantra is that perseverance and collaboration lead to breakthroughs.

He lends his expertise to international commissions charting the future of the field such as the Human microbiome action and the European commission. Driven by scientific rigor and a vision to improve human health, he is at the vanguard of a new era in microbiome research and therapeutics.

Propiontherapeutics
Propiontherapeutics

Jacob Azevedo

Head of Partnerships

Jacob Azevedo is the co-owner of EverSpan Life and a manufacturing company that supplies pharmacies with GLP-1 agonists. He is an investor in multiple biohacking and nutritional companies.

Propiontherapeutics
Propiontherapeutics

Maryann Walsh

Operational Board Member

Maryann Walsh is a Registered Dietitian, Certified Personal Trainer, Certified Diabetes Educator and owner of Walsh Nutrition Consulting based in Palm Beach, Florida. As a subject matter expert in nutrition and weight management, Maryann has worked with brands such as SlimFast, Glanbia Nutritionals, Sprouts Farmers Market, Vitamin Shoppe and Breyers Ice Cream among others where she provided representation in publications, copywriting, product and program development as well as social media content creation.

Propiontherapeutics
Propiontherapeutics

Scott Fulton

Operational Board Member

Scott Fulton is a change agent at the intersection of aging, healthspan, and the built environment. An engineer by training, Fulton’s early corporate research collaborations set the stage for solving big challenges. Leading change has been a constant across a divergent career from concept and ideation to scale-up.

A pragmatic systems thinker, his sights are set on raising the trajectory of US Healthspan and Life Expectancy to world-class. Scott is President of Home Ideations, President of the National Aging in Place Council, a member of the American College of Lifestyle Medicine, and sits on multiple Boards. Fulton also teaches adults on aging at the Universities of Virginia and Delaware campuses.

He’s a podcast host and author, with his latest book, WHEALTHSPAN™, due out in early 2024.

Propiontherapeutics
Propiontherapeutics

Scott Fulton

Operational Board Member

Scott Fulton is a change agent at the intersection of aging, healthspan, and the built environment. An engineer by training, Fulton’s early corporate research collaborations set the stage for solving big challenges. Leading change has been a constant across a divergent career from concept and ideation to scale-up.

A pragmatic systems thinker, his sights are set on raising the trajectory of US Healthspan and Life Expectancy to world-class. Scott is President of Home Ideations, President of the National Aging in Place Council, a member of the American College of Lifestyle Medicine, and sits on multiple Boards. Fulton also teaches adults on aging at the Universities of Virginia and Delaware campuses.

He’s a podcast host and author, with his latest book, WHEALTHSPAN™, due out in early 2024.

Propiontherapeutics
Propiontherapeutics

Dr. Bill Andrews

Board of Directors

Scientific Advisory Board

Dr. Bill Andrews is the Founder and CEO of Sierra Sciences, a company focused on finding ways to extend human lifespan and health span. Bill received his Ph.D. in Molecular & Population Genetics in 1981 from the University of Georgia.

Before founding Sierra Sciences Bill was a medical researcher at Armos Corporation, Codon Corporation, Berlex Biosciences, Geron Corporation, and EOS Biotech. His research focused on cancer, heart disease, inflammation, and aging. Bill played key roles in the discoveries of Human Growth Hormone, Tissue Plasminogen Activator, Osteo-Inductive Factor, Erythropoietin, Beta-Seron, Telomerase, and Imetelstat, to name a few.

In 1997 Bill was awarded 2nd Place as National Inventor of the Year for his cancer research. In the early-to-mid 1990s, while at Geron Corporation, Bill led the research to discover both the RNA and protein components of human telomerase, the enzyme responsible for preventing telomeres from shortening in our reproductive cells. Presently, the primary focus of Sierra Sciences is to find ways to produce telomerase and lengthen telomeres in all cells of the human body.

Propiontherapeutics

info@propionhealth.com

OUR FIRST PRODUCT

Propion BLEND™

Propion BLEND™ is a proprietary combination of amino acids, superfoods, and proteins which gives bacteria in your gut the molecular building blocks for assembling the longevity-promoting metabolites mentioned above.

Get on the waiting list and be one of the first people to access the Propion BLEND™

Executive Team

Get to know the talented individuals behind our success. Our dedicated team brings a wealth of expertise and passion to every project, ensuring exceptional results and client satisfaction

Propiontherapeutics

Nicholas Tubach

Chief Executive Officer

Nicholas Tubach is a serial biotech entrepreneur. In addition to his work as the CEO of Propion AKA How to Slow Time, Inc.

Propiontherapeutics

Dr. Jan Scicinski

Head of Medicinal Chemistry

Dr Jan Scicinski is an experienced drug discovery and development scientist, executive, and problem solver with a successful track record in new pharmaceutical product...

Propiontherapeutics

Dr. Daniel Winer

Scientific Director

Dr. Daniel Winer is an Associate Professor at the Buck Institute for Research on Aging with affiliation to the University of Southern California.

Propiontherapeutics

Jacob Azevedo

Head of Partnerships

Jacob Azevedo is the co-owner of EverSpan Life and a manufacturing company that supplies pharmacies with GLP-1 agonists. He is an investor in multiple biohacking and nutritional companies.

Propiontherapeutics

Marco Quarta

Head of Translational Research

Dr. Marco Quarta earned a Masters degree in Biotechnology, a PhD in Neuroscience, and post-doctoral training in Aging and Stem Cells Biology at Stanford University School of Medicine.

Propiontherapeutics

Maryann Walsh

Operational Board Member

Maryann Walsh is a Registered Dietitian, Certified Personal Trainer, Certified Diabetes Educator and owner of Walsh Nutrition Consulting based in Palm Beach, Florida. As a subject matter expert in nutrition and weight management...

Propiontherapeutics

Dr. Amine Zorgani

Operational Board Member

Amine, is a microbiome expert on a mission to save the human microbiome from extinction. Leveraging over a decade of research experience, he is at the forefront of efforts to unlock the potential of the microbiome...

Propiontherapeutics

Scott Fulton

Operational Board Member

Scott Fulton is a change agent at the intersection of aging, healthspan, and the built environment. An engineer by training, Fulton’s early corporate research collaborations set the stage for solving big challenges...

Propiontherapeutics

Dr. Bill Andrews

Board of Directors

Scientific Advisory Board

Dr. Bill Andrews is the Founder and CEO of Sierra Sciences, a company focused on finding ways to extend human lifespan and health span. Bill received his Ph.D. in Molecular & Population Genetics in 1981 from the University of Georgia.

Contact Us

Reach out to us easily for inquiries, collaborations, or any assistance you need. We're here to listen and help you achieve your goals